932 related articles for article (PubMed ID: 30506812)
21. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.
Kats A; Båge T; Georgsson P; Jönsson J; Quezada HC; Gustafsson A; Jansson L; Lindberg C; Näsström K; Yucel-Lindberg T
FASEB J; 2013 Jun; 27(6):2328-41. PubMed ID: 23447581
[TBL] [Abstract][Full Text] [Related]
23. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts.
Tanaka H; Tanabe N; Shoji M; Suzuki N; Katono T; Sato S; Motohashi M; Maeno M
Life Sci; 2006 Mar; 78(15):1733-40. PubMed ID: 16266722
[TBL] [Abstract][Full Text] [Related]
24. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
25. A challenge with Porphyromonas gingivalis differentially affects the osteoclastogenesis potential of periodontal ligament fibroblasts from periodontitis patients and non-periodontitis donors.
Sokos D; Scheres N; Schoenmaker T; Everts V; de Vries TJ
J Clin Periodontol; 2014 Feb; 41(2):95-103. PubMed ID: 24164598
[TBL] [Abstract][Full Text] [Related]
26. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
[TBL] [Abstract][Full Text] [Related]
28. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue.
Oka H; Miyauchi M; Furusho H; Nishihara T; Takata T
J Periodontol; 2012 Apr; 83(4):506-13. PubMed ID: 21910594
[TBL] [Abstract][Full Text] [Related]
29. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
[TBL] [Abstract][Full Text] [Related]
30. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions.
El Kholy K; Freire M; Chen T; Van Dyke TE
Front Immunol; 2018; 9():1300. PubMed ID: 29946319
[TBL] [Abstract][Full Text] [Related]
31. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
[TBL] [Abstract][Full Text] [Related]
32. Regulation of OPG and RANKL expressed by human dental follicle cells in osteoclastogenesis.
Sun H; Li Q; Zhang Y; Bi Y; Li X; Shu Y; Chen X; Jin Z; Ge C
Cell Tissue Res; 2015 Nov; 362(2):399-405. PubMed ID: 26149648
[TBL] [Abstract][Full Text] [Related]
33. Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2).
Mayahara K; Yamaguchi A; Takenouchi H; Kariya T; Taguchi H; Shimizu N
Arch Oral Biol; 2012 Oct; 57(10):1377-84. PubMed ID: 22884709
[TBL] [Abstract][Full Text] [Related]
34. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts.
de Vries TJ; Schoenmaker T; Wattanaroonwong N; van den Hoonaard M; Nieuwenhuijse A; Beertsen W; Everts V
J Cell Biochem; 2006 May; 98(2):370-82. PubMed ID: 16440316
[TBL] [Abstract][Full Text] [Related]
35. Dual modulation of osteoclast differentiation by lipopolysaccharide.
Zou W; Bar-Shavit Z
J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway.
Wu X; Zhao K; Fang X; Lu F; Zhang W; Song X; Chen L; Sun J; Chen H
Drug Des Devel Ther; 2021; 15():4741-4757. PubMed ID: 34848946
[TBL] [Abstract][Full Text] [Related]
37. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
[TBL] [Abstract][Full Text] [Related]
38. Roles of cathelicidin-related antimicrobial peptide in murine osteoclastogenesis.
Horibe K; Nakamichi Y; Uehara S; Nakamura M; Koide M; Kobayashi Y; Takahashi N; Udagawa N
Immunology; 2013 Nov; 140(3):344-51. PubMed ID: 23826736
[TBL] [Abstract][Full Text] [Related]
39. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D
BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296
[TBL] [Abstract][Full Text] [Related]
40. The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption.
Coon D; Gulati A; Cowan C; He J
J Endod; 2007 Apr; 33(4):432-6. PubMed ID: 17368333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
